Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Nabriva Therapeutics plc (NBRV) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.45 Metrics
OS: 3.06 M -185 % ROE
Market cap: $4.44 M -257 % ROIC
Net cash: $8.52 M $2.78 per share
EV:

 
TTM Valuation
EBITDA
EBIT ($46.0) M
EPS ($4.82)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues28.95.09.59.75.36.53.82.4
            Revenue growth474.8%-47.0%-1.8%81.5%-17.9%72.1%57.1% 
Cost of goods sold13.1-0.8-0.10.00.00.00.00.0
Gross profit15.75.89.69.75.36.53.82.4
            Gross margin54.5%115.2%100.7%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative51.655.362.541.729.5   
Research and development12.615.126.482.349.648.023.69.4
General and administrative     13.57.93.7
EBIT-48.5-66.1-79.5-114.4-73.8-55.0-27.8-10.7
            EBIT margin-167.9%-1315.4%-838.4%-1184.5%-1386.9%-849.2%-736.9%-446.0%
Pre-tax income-49.0-69.3-82.7-114.7-73.0-55.6-47.4-14.1
Income taxes0.50.10.10.01.4-0.7-0.40.1
            Tax rate     1.2%0.9% 
Net income-49.5-69.5-82.8-114.8-74.4-54.9-47.0-14.2
            Net margin-171.1%-1382.2%-872.9%-1188.7%-1397.9%-846.8%-1246.7%-593.1%
 
Diluted EPS($1.14)($5.41)($11.15)($22.60)($2.49)($2.56)($4.44)($43.80)
Shares outstanding (diluted)43.312.87.45.129.821.510.60.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy